« Previous
Next »
Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 3
, Pages 158-161
, June 2010
Insulin Resistance and Adolescent Girls with Polycystic Ovary Syndrome
References
- . Consensus Development Conference on Insulin Resistance. Diabetes Care. 1998;21:310
- . Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 1979;237:E214
- . A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1999;83:2694
- . Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2002;15(Suppl 5):1367
- . Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;9:41
- Prevalence and predictors of risk for Type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165
- . Polycystic ovary syndrome: a diagnostic challenge. Obstet Gynecol Clin N Am. 2003;14:197
- . Polycystic ovary syndrome in adolescence–a therapeutic conundrum. Hum Reprod. 2004;19:1039
- Prediction model for insulin resistance in the polycystic ovary syndrome. Hum Reprod. 2000;15:1098
- Insulin sensitivity, insulin secretion and metabolic and hormonal parameters in healthy women and women with polycystic ovary syndrome. Hum Reprod. 2000;15:1266
- . Polycystic ovary syndrome and insulin resistance: thrifty genes struggling with over-feeding and sedentary life style?. J Endocrinol Invest. 1998;21:589
- Insulin sensitivity and beta cell function in women with polycystic ovary syndrome. Diabetes Care. 2002;25:1217
- . Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18:774
- . C-reactive protein, its role in inflammation, Type 2 diabetes and cardiovascular disease, and the effects of insulin-sensitizing treatment with thiazolidinediones. Diabet Med. 2004;21:810
- . Role of the adipocyte, free fatty acids, and ectopic fat in the pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J Clin Endocrinol Metab. 2004;89:163
- . Insulin resistance and the endothelium. Am J Med. 2004;117:109
- . Tissue-specific glucocorticoid reactivating enzyme, 11-beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)–a promising drug target for the treatment of metabolic syndrome. Curr Drug Targets Immune Endocr Metab Disord. 2003;3:255
- Acanthosis nigricans as a risk factor for non-insulin dependent diabetes mellitus. Clin Paediatr. 1998;37:13
- . Polycystic ovary syndrome: early detection in the adolescent. Clin Obstet Gynecol. 2007;50:178
- Insulin resistance in adolescents with menstrual irregularities. J Pediatr Adolesc Gynecol. 2005;18:269
- Sex hormone-binding globulin during puberty in normal and hyperandrogenic girls. J Pediatr Endocrinol Metab. 2000;13:1277
- . Polycystic ovary syndrome in adolescence. Semin Reprod Med. 2003;21:301
PII: S1083-3188(09)00347-7
doi: 10.1016/j.jpag.2009.10.004
© 2010 North American Society for Pediatric and Adolescent Gynecology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Pediatric and Adolescent Gynecology
Volume 23, Issue 3
, Pages 158-161
, June 2010
